Pharmaron Beijing Co., Ltd. (SHE:300759)
China flag China · Delayed Price · Currency is CNY
40.90
-0.70 (-1.68%)
Nov 17, 2026, 3:04 PM CST

Pharmaron Beijing Revenue

Pharmaron Beijing had revenue of 4.41B CNY in the quarter ending September 30, 2026, with 20.94% growth. This brings the company's total for the last twelve months to 16.01B, up 18.23% year-over-year. In the year 2025, Pharmaron Beijing had annual revenue of 14.10B with 14.82% growth. That makes Pharmaron Beijing the 4,429th largest company in the world by revenue and 564th in China.

Revenue (ttm)
16.01B
Revenue Growth
+18.23%
P/S Ratio
4.37
Revenue / Employee
638.27K
Employees
27,316
Market Cap
68.84B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Laboratory Services (Excl. Macromolecule and Cell and Gene Therapy Services) 8.16B 57.9%
  • CMC (Small Molecule CDMO) Service 3.48B 24.7%
  • Clinical Research Services 1.96B 13.9%
  • Chemical and Formulation Process Development and Manufacturing Services 474.69M 3.4%
  • Others 21.90M 0.2%

By Geography

Chart
  • North America 8.71B 61.8%
  • Europe 2.89B 20.5%
  • Mainland China 2.14B 15.2%
  • Asia (Excluding Chinese Mainland) 298.44M 2.1%
  • Others 50.69M 0.4%
Fiscal year ended Dec 31, 2025 See the full Pharmaron Beijing breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202514.10B1.82B14.82%
Dec 31, 202412.28B737.78M6.39%
Dec 31, 202311.54B1.27B12.39%
Jan 1, 202310.27B2.82B37.92%
Dec 31, 20217.44B2.31B45.00%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.